Effect of androgen suppression on hemoglobin in prostate cancer patients undergoing salvage radiotherapy plus 2-year buserelin acetate for rising PSA after surgery

International Journal of Radiation Oncology Biology Physics

Volumn 62, Issue 3, 2005, Pages 719-724

  Chander, Sarat ^a,b   Choo, Richard ^a,c   Danjoux, Cyril ^a   Morton, Gerard ^a   Pearse, Andrew ^a   Deboer, Gerrit ^a   Szumacher, Ewa ^a   Loblaw, Andrew ^a   Cheung, Patrick ^a   Woo, Tony ^a  

^a DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^b WELLINGTON HOSPITAL   (New Zealand)

^c MAYO CLINIC   (United States)

Author keywords

Androgen suppression; Erythropoiesis; Hemoglobin; LHRH agonists; Prostate cancer

Indexed keywords

HEMOGLOBIN; MEDICAL IMAGING; PATIENT MONITORING; PROSTHETICS; RADIOTHERAPY; TUMORS;

ANDROGEN SUPPRESSION (AS); PROSTRATE-SPECIFIC ANTIGENS; QUALITY-OF-LIFE; TESTOSTERONE;

HORMONES;

ANDROGEN; BUSERELIN ACETATE; HEMOGLOBIN; NILUTAMIDE; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; EVALUATION; FATIGUE; FOLLOW UP; HEMATOCRIT; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATECTOMY; QUALITY OF LIFE; QUESTIONNAIRE; TESTOSTERONE BLOOD LEVEL;

AGED; ANTINEOPLASTIC AGENTS, HORMONAL; BUSERELIN; FATIGUE; HEALTH STATUS; HEMATOCRIT; HEMOGLOBINS; HUMANS; MALE; PROSTATECTOMY; PROSTATIC NEOPLASMS; QUALITY OF LIFE; SALVAGE THERAPY; TESTOSTERONE;

EID: 20344375441     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2004.11.008     Document Type: Article

References (16)

1. E.P. McCullagh, T.R. Jones A note on the effect of certain androgens upon the red blood cell count and upon the glucose tolerance Cleveland Clin Quart 8 1941 79
2. P. Steinglass, A.S. Gordon, H.A. Charripper Effect of castration and sex hormones on blood of rat Proc Soc Exp Biol Med 48 1941 169
3. A. Locascuilli, F. Porta, J.M. Vossen Treatment of acquired severe aplastic anemia (SAA) in children An analysis of EBMT-SAA working party [Abstract] Bone Marrow Transplant 4 Suppl. 2 1989 90
4. N. Dainaik The role of androgens in the treatment of anemia of chronic renal failure Semin Nephrol 5 1985 147 154
5. P.F. Molinari Erythropoietic mechanism of androgens A critical review and clinical implications Haematologica 67 1982 442 460
6. S.M. Garn, A.S. Ryan, S. Abraham Suggested sex and age appropriate values for "low" and "deficient" hemoglobin levels Am J Clin Nutr 34 1981 1648 1651
7. M.E. Miller, M. Chandra, J.F. Garcia Clinical applications of measurement of serum immunoreactive levels of erythropoietin Ann NY Acad Sci 459 1985 375 381
8. J.P. Weber, P.C. Walsh, C.A. Peters Effect of reversible androgen deprivation on hemoglobin and serum immunoreactive erythropoietin in men Am J Hemat 36 1991 190 194
9. L.M. Eri, K.J. Tveter Safety, side effects and patient acceptance of the luteinizing hormone releasing hormone agonist leuprolide in the treatment of benign prostatic hyperplasia J Urol 152 1994 448 452
10. S.O. Asbell, S.A. Leon, W.J. Tester Development of anemia and recovery in prostate cancer patients treated with combined androgen blockade and radiotherapy Prostate 29 1996 243 248
11. R. Fonseca, S.V. Rajkumar, W.L. White Anemia after orchiectomy Am J Hematol 59 1998 230 233
12. S.B. Strum, J.E. McDermed, M.C. Scholz Anemia associated with androgen deprivation in patients with prostate cancer receiving combined hormone blockade Br J Urol 79 1997 933 941
13. D. Osaba, G. Rodrigues, J. Myles Interpreting the significance of changes in health-related quality-of-life scores J Clin Oncol 16 1998 139 144
14. J.B. Hamilton Role of testicular secretions as indicated by effects of castration in man and by studies of pathological conditions and short lifespan associated with maleness Recent Prog Horm Res 3 1948 257 289
15. C.A. McArdle, J. Franklin, L. Green The gonadotrophin-releasing hormone receptor Signaling, cycling and desensitization Arch Physiol Biochem 110 2002 113 122
16. T. Pickles, P. Graham What happens to testosterone after prostate radiation monotherapy and does it matter? J Urol 167 2002 2448 2452